NHS
Fiscal year ends October Quarters are offset from the calendar — Q1 is Nov–Jan

Neuberger High Yield Strategies Fund Inc. is a closed-end management investment company that seeks current income consistent with preservation of capital and growth of capital. The Fund invests primarily in high yield debt securities, including below investment grade corporate bonds, bank loans, and other fixed income instruments. Neuberger Berman Investment Advisers LLC (NBIA) serves as the investment manager, making investment decisions for the Fund's assets. The Fund operates under the Neuberger fund complex, with NBIA providing investment management, administrative, and advisory services. The Fund's board of directors oversees management through various standing committees, including the Audit Committee, Closed-End Funds Committee, Contract Review Committee, Ethics and Compliance Committee, Executive Committee, Governance and Nominating Committee, and Investment Performance Committee. The Fund faces risks such as investment risk, counterparty risk, valuation risk, liquidity risk, and cybersecurity risk, which are managed through processes and controls overseen by the board and management.

Summarised from the merger proxy statement/prospectus, filed Feb 2026

Industry Asset Management Homepage nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx
Sector Financial Services IR page —
Tags
closed-end fund, high yield debt, fixed income, below investment grade, bank loans, capital preservation, capital growth, Neuberger High Yield Strategies Fund Inc., NBIA, Neuberger Berman Investment Advisers LLC, Neuberger fund complex, State Street
Press page —

Metrics

Valuation  
Market cap $ 226.858M
Market cap (USD) $ 226.858M
P/E 9.03
PEG —
P/BV 0.79
P/S 9.74
Discount/premium to NAV 0.81%
P/OCF 62.64
P/FCF 62.64
Dividend yield 20.1%
Turnover / mcap —
Returns  
ROE 8.6%
ROI 6.9%
ROIC 3.9%
Profit margin 86.8%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 2
Quality score -11.8%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018
Revenue 23.285M 41.748M 9.742M -30.379M — — 0
Net profit 20.216M 37.94M 3.718M -33.489M — — 0
Free cash flow 3.622M 21.105M -5.849M -48.69M — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2018
Share price 7.5 8.67 — — 12.67 11.09 —
Price performance 12m -0.13 0.15 — — 0.14 -0.08 —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Prompts

Neuberger High Yield Strategies Fund Inc. (ticker NHS), listed in United States.

Company History

Date Change Detail
Dec 23, 2025 Renamed Neuberger Berman High Yield Strategies Fund Inc. → Neuberger High Yield Strategies Fund Inc.

ETFs Holding Neuberger High Yield Strategies Fund Inc.

ETF Weight in ETF Shares Market value As of
CEFZ 0.48% 31,542.0003 $ 189.252K Jul 31, 2026